{
  "id": 20086353,
  "title": "Scotts Miracle-Gro director David Evans sells $176,345 in shares",
  "url": "https://urgent.news/2026/11/15/scotts-miracle-gro-director-david-evans-sells-176-345-in-shares",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-15T00:15:47.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/scotts-miraclegro-director-david-evans-sells-176345-in-shares-93CH-5027595"
  },
  "original_language": "en",
  "account": "Scotts Miracle-Gro's director, David Evans, sold 2,655 of the company's shares on November 9, 2026, for a total of $176,345. This transaction occurred at a price of $66.42 per share, which is higher than the current trading price of $63.84. According to InvestingPro analysis, Scotts Miracle-Gro appears undervalued, making it a potential opportunity on the most undervalued stocks list. Post-transaction, Mr. Evans now holds 25,405 common shares of the company. The business has consistently paid dividends for 22 consecutive years, currently offering a yield of 4.14%. For those interested in a more in-depth analysis of Scotts Miracle-Gro's valuation and financial status, the Pro Research Report is available, covering this and 1,400+ other US equities.\n\nIn related news, Scotts Miracle-Gro released its fiscal fourth-quarter results. While the adjusted loss per share was smaller than expected at $2.16 compared to the forecasted $2.21, revenue fell slightly short of expectations at $302.9 million against the forecasted $306.1 million. Despite these modest results, the company's management remains optimistic for fiscal 2027, projecting a growth in net sales between 2% and 4% and adjusted earnings per share growth of approximately 5% to 9%.\n\nFurther buoying investor confidence, Wells Fargo raised its price target for Scotts Miracle-Gro from $71 to $76, maintaining an Overweight rating. This decision was driven by the firm's analyst, Michael Ruch, who lauded the company's growth outlook as a significant factor. These recent developments portray a generally positive outlook among analysts for the company's future performance.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}